Board of Directors
Corporate policy is to list directors and Science Advisory Board members
Bret T. Barnhizer
Chairman of the Board, CEO, and President
During the past 13+ years as CEO of Nanologix, Mr. Barnhizer has worked to further the interests of NanoLogix and to bring its rapid detection technologies to the attention of multiple organizations for their use in combatting infection. Working as part of a small team of like-minded individuals dedicated to this effort, against heavy odds in a field dominated by large well-established corporations, NanoLogix has begun to penetrate the diagnostics market and capture market share. Prior to becoming CEO, Mr. Barnhizer had a successful 25+ year career in the upstream oil and gas industry, working for BP, Chevron, Unocal, Occidental and many others as both consultant and employee, with his last position based in Europe as Manager for European Operations for an independent Canadian oil and gas company.
In his career in the oil and gas industry his innovation and leadership led to the adoption of breakthrough technology applications that are now widely used in the industry. These applications have provided dramatically improved economics and performance in upstream operations with savings to date from 1989 estimated at billions of dollars. Mr. Barnhizer worked as Coastal Sales and Engineering manager for a California oilfield service company and was Vice President for Marketing and Sales for Anacapa Salt & Chemical Inc. Moving from sales and localized engineering into upstream exploration and drilling operations, Mr. Barnhizer provided engineering, project, and operations management services to companies in the U.S., Europe, Africa and Asia, living for extended periods on three continents outside North America. Mr. Barnhizer is a U.S. Army veteran of the Vietnam War, where during his two tours of duty he served as a battlefield combat medic, followed by temporary duty with a USARV Military Advisory Team, providing medical aid and services to Vietnamese civilians as the equivalent of a doctor in four villages and hamlets. Afterwards he managed medical inventory and field resupply for a US Infantry Battalion engaged in active combat, in addition to continued service on Medical Civil Action Programs (MEDCAP) in the Danang area assisting Battalion Surgeons and others in treatment of children in local orphanages. Following the military, Mr. Barnhizer attended Youngstown State University and the University of Colorado, followed by his career in the oil and gas industry.
Mr. Barnhizer is the inventor of the “flatpack” packaging used for the commercial sales of Nanologix’s various petri products. The packaging provides for dramatically extended shelf life and increased efficacy in use for nutrient media used for bacteria detection. He is also the originator of the concept of the use for aptamers in place of antibodies for diagnostics. This concept has led to the filing of a separate patent covering the potential. He is the co-inventor of the N-Assay and the Rapid Viral Assay.
John Chatterton is one of the world’s most accomplished and well-known underwater explorers. He is a consultant to the film and television industries, and has worked with Discovery Channel, PBS, CBS, HBO, 20th Century Fox and Paramount Pictures.
Jeff Long originally a reporter and novelist with treatments of his novels used for film, has also written and developed advertising and catalogs for various companies, including Overseas Adventure Travel, Lowe Alpine Systems, Thompson Safaris, and others. He is the founder of Witness Inc., a human rights and foreign aid group.
Jonathan Faro, PhD, MD
Director & Chief Medical Officer
Dr. Faro is the co-inventor of the N-Assay modified ELISA bacteria-detection and identification technology and primary author of a number of published peer-reviewed research papers on the technology.
Chief Science Officer
James Rogers, PhD, has more than 20 years of biomedical research experience within U.S. Government, contract research organization, and biotechnology industries. This experience includes serving as a Study Director, Principal Investigator, Subject Matter Expert (SME), and Operations Manager executing studies supporting research and development, testing and evaluation, preclinical, and clinical support studies.
From his more than 15 years working at Battelle, Dr. Rogers brings vast experience specializing in the testing and evaluation of medical countermeasures for biological and chemical threat agents. This experience includes transcriptomics/bioinformatics, microRNA analysis, and immunological techniques to investigate biochemical pathways underlying host responses as well as the identification of biomarkers and potential therapeutic targets. He led the development and qualification/validation of several molecular and immune assays to support immunogenicity evaluation, biodistribution studies of vaccines, and clinical trials. He also served as the SME and Program Director for projects that included persistence and decontamination of biological/chemical agents, diagnostic kit and detector testing, and immunotoxicology.
Dr. Rogers received his PhD in Biomedical Sciences from Wright State University, focusing on skin immunology and DNA vaccines. He worked as a post-doc for Geo-Centers, Inc. within the U.S. Air Force Research Laboratory at Wright-Patterson Air Force Base. His research focused on molecular mechanisms associated with volatile organic chemical-induced skin irritation using three-dimensional in vitro and in vivo models.
Dr. Rogers is an author on more than 60 scientific publications and book chapters, presented at national scientific meetings, actively serves on multiple scientific journal Editorial Boards, and served as Book Editor of Microarrays: Principles, Applications and Technologies (Nova Science Publishers, 2014).